Wang J P
Zhonghua Zhong Liu Za Zhi. 1986 Jan;8(1):73-5.
From Feb. 1981 to Oct. 1983, 31 patients with advanced cancer of lung, nasopharynx, uterine cervix, breast, malignant lymphoma and others, with extensive metastasis and severe pain, were treated by HBI. The routine therapy would not have relieved the patients of such pain. 60Co was used (SSD 180 cm, dose rate 23-25 rad/min, single mid plane dose 800 rad). Six patients received a second radiation after the first one, 37 courses of HBI were performed in 31 patients (5 times for the upper half and 32 for the lower half). In 32 out of 37 courses of HBI, the pain was partially or completely relieved with a relief rate of 86% and a complete relief rate of 46%. The authors believe that HBI for advanced cancer is superior to any other means. A dose of 800 rad can shrink the tumor or render it subsided temporarily even though not curing it. The side effects on the digestive tract and blood picture were tolerable.
1981年2月至1983年10月，对31例患有晚期肺癌、鼻咽癌、子宫颈癌、乳腺癌、恶性淋巴瘤及其他癌症且有广泛转移和剧烈疼痛的患者采用半身照射（HBI）治疗。常规治疗无法缓解这些患者的此类疼痛。使用了60钴（源皮距180厘米，剂量率23 - 25拉德/分钟，单次中平面剂量800拉德）。6例患者在首次照射后接受了第二次放疗，31例患者共进行了37个疗程的半身照射（上半身5次，下半身32次）。在37个疗程的半身照射中，有32个疗程疼痛部分或完全缓解，缓解率为86%，完全缓解率为46%。作者认为，晚期癌症的半身照射优于任何其他方法。800拉德的剂量可使肿瘤缩小或暂时消退，尽管无法治愈。对消化道和血象的副作用是可以耐受的。
